LPTX
Leap Therapeutics Inc
Halal Rating :
Last Price
$2.55
Last updated:
Market Cap
-
7D Change
-17.74%
1 Year Change
-16.12%
Company Overview
Industries
Exchange
Next Earnings Date
Leap Therapeutics Inc is a biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics. The company's primary focus is on developing novel therapies for cancer treatment. Their lead program, DKN-01, is a monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, which is currently being evaluated in clinical trials for various types of cancers.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Leap Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.